Skip to content

FREEDOM: "Pilot Study of the Feasibility and Safety of Resuming Early Walking After Manual Compression in Patients Treated for Peripheral Artery Disease by Endovascular Technique Involving Retrograde Femoral Puncture"

FREEDOM: "Pilot Study of the Feasibility and Safety of Resuming Early Walking After Manual Compression in Patients Treated for Peripheral Artery Disease by Endovascular Technique Involving Retrograde Femoral Puncture"

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02198612
Acronym
FREEDOM
Enrollment
30
Registered
2014-07-23
Start date
2015-03-01
Completion date
2015-09-01
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Brief summary

Over the past years, arterial closure systems have tended to replace manual compression to ensure hemostasis at femoral artery puncture points. Arterial closure systems reduce hemostasis and patient immobilization times, thus enabling early resumption of walking. These devices have contributed extensively to the development of outpatient stays for cardiology, vascular and neuro-radiology procedures. According to certain studies however, it would appear that arterial closure devices do not present any greater benefits than manual compression in terms of hemostasis and complications. Moreover, the use of increasingly small diameter instruments would tend to render manual compression sufficient. Finally, the use of these devices generates additional costs. The purpose of our study is to evaluate the feasibility and safety of manual compression before early resumption of walking in patients managed by conventional hospitalization for a diagnostic or therapeutic endovascular procedures by retrograde femoral puncture with 5F guide catheter.

Interventions

Manual puncture point compression following a diagnostic or therapeutic procedure by endovascular technique involving retrograde femoral puncture point with 5F guide catheter

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years, * Endovascular examination or treatment compatible with a 5F guide catheter * Walking ability * Patient affiliated with a social security scheme * Patient's signed informed consent form

Exclusion criteria

* Underage patient * Patient of age, but under legal guardianship or care * Contraindication to endovascular treatment * Use of a 6F or greater guide catheter * Morbidity contraindicating same-day walking * History of punctured open femoral triangle surgery * Radial or humeral puncture * Bilateral femoral puncture * Anterograde femoral puncture * Acute ischemia * Anticoagulant treatment * Allergy to Elastoplast® type adhesive strips * Life expectancy of less than one month * Patient refusal to take part in the study * Participation in another therapeutic trial * Pregnant woman * Patients who do not speak French, refusing or incapable of the follow-up proposed by the study

Design outcomes

Primary

MeasureTime frameDescription
Resumption of walking at H5 will be evaluated by a walking testHour 5To demonstrate the feasibility of early resumption of walking after manual puncture point compression following a diagnostic or therapeutic procedure by endovascular technique involving retrograde femoral puncture point with 5F guide catheter.

Secondary

MeasureTime frame
Occurrence of major punctured femoral triangle events during the perioperative period, requiring prolongation of hospitalization, repeat hospitalization or repeat surgery (hematoma, hemorrhage or false aneurysm)Hour 5
Occurrence of minor punctured femoral triangle events during the perioperative period, not requiring prolongation of hospitalization, repeat hospitalization or repeat surgeryHour 5
Time to onset of complicationsHour 5
Puncture point pain (visual analog scale of pain)Hour 5
Quality of life evaluation (EQ5D questionnaire)Month 1
Compression timeHour 5

Countries

France

Contacts

STUDY_CHAIRYann GOUEFFIC, Professor

Nantes University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026